-
August 29, 2018PREVIEW
Kala Pharmaceuticals announced FDA approval of loteprednol etabonate ophthalmic suspension 1...
-
August 28, 2018PREVIEW
FDA approved stiripentol for the treatment of seizures associated with Dravet syndrome, a rare form of epilepsy. Stiripentol is indicated for use in patients aged 2 years and older who are taking...
-
August 21, 2018PREVIEW
FDA granted accelerated...
-
August 21, 2018PREVIEW
...
-
August 21, 2018PREVIEW
...
Pages
